Infusion Pumps – Infusing the Care in Healthcare
Patient-controlled analgesia infusion pumps are commonplace in healthcare settings and are widely used to transfer medications, nutrients, and fluids to the patient body at preset intervals in accurate dosages. The infusion of fluids and medication into the patient venous system play a vital role in current therapeutic regimens and are used across the length and breadth of healthcare settings right from inpatient, outpatient, and private clinics to at-home settings. A myriad range of infusion pumps such as peripheral venous catheters, central venous catheters, peripherally inserted central catheters (PICCs), implants and epidural catheters are used as per requirement. The type of delivery or the device used for fluid and medication delivery mainly depends on the condition of the patient receiving the therapy. The adoption of such devices in different application is expected to fuel growth of the infusion pumps market.
Infusion pumps have revolutionized the administration of intravenous medications with potentially game changing programming features such as intermittent and preprogramming, bolus dosing, and standby mode. According to a featured article by Wolters Kluwer Health, Inc., in 2007, around 90% of hospitalized patients in the U.S. received IV medications, most being delivered by an infusion pump. This trend argues favorably for growth of the infusion pumps market in the foreseeable future. In spite of being a precise fluid and medication transferring devices still, 35%-60% of the 700,000 adverse drug events (ADEs) annually reported in the U.S. are related to delivery through infusion pumps, which can further cause morbidity and mortality. This has necessitated extensive focus by players in the global infusion pumps market on R&D to reduce error rates associated with infusion pumps and introduce further advancements in existing products. For instance, according to Qual Saf Health Care’s research paper, in 2009, there were recommendations to use smart infusion devices to overcome the errors in infusion and favor the growth of the global infusion pumps market. Manufacturers have developed devices that have dose error reduction systems (DERS) with dosing limits and clinical advisories under hospital-defined drug libraries. Smart pumps are now being designed with safety software that are drug-specific.
The global infusion pumps market was valued at US$ 2,985.5 million in 2015 and is expected to witness a moderate CAGR of 6.0% during the forecast period (2016 – 2024).
Figure 1. Global Infusion Pumps Market Size and Forecast, US$ Million and Y-o-Y Growth (%), 2014–2024
Source: Coherent Market Insights Analysis (2017)
To have a snippet of the report, request Report Sample
Key players in the infusion pumps market are focusing on reducing error rates
Major investments are being made by key players for the advancement of products that are used in the infusion pumps devices, owing to increasing number of applications and better return on investment. For instance, an update from VertMarkets, Inc. revealed that Baxter is developing a new infusion pump platform, reinvigorating bio-surgery sector. Also, companies are focusing on product advancements to increase application area of infusion pumps for analgesic applications. According to Journal of Emergency Medical Services, in 2017, an infusion pump system can be an important breakthrough for ketamine delivery, which is to begin with a bolus dose, followed by a drip. Furthermore, increasing prevalence of chronic pain and rising population who are suffering from various types of cancer are other factors that create a conducive environment for infusion pumps market growth. Also, rising prevalence of gastroenterological procedures worldwide are expected to underpin the infusion pumps market growth. In 2016, according to the National Cancer Institute, around 1,685,210 new cases of cancer were diagnosed in the U.S., which are projected to lead to around 595,690 fatalities.
Application-specific products an emerging strategy adopted by infusion pumps market players
Well managed and schematic approach towards integration of major players followed by various acquisitions in infusion pumps market is expected to fuel the product advancement and product introduction in the infusion pumps market. According to CareFusion Corporation, in 2013, around 61% of most costly and serious medication errors were related to intravenous infusions in the U.S., which was the major concern of the hospitals to make the system error free and effortless. To address the same, CareFusion Corporation introduced a new system named Alaris System, having Guardrails Suite MX software and combines a single point-of-care unit. This is expected to minimize the infusion errors in the future. As statistics suggest, there were significant number of mergers and acquisition that have added to the development and advancement of new infusion pumps products. For instance:
Increasing number of research collaborations are expected to improve the time-to-market of highly effective and advanced products.
An infusion pump delivers medications and nutrients to patients who cannot take the same orally. These devices find wide application in hospitals to administer drugs in a controlled rate as programmed by the healthcare professional. These pumps offer various advantages over manual administration of medications or any other fluids such as automated delivery of fluids in smaller volumes at preset intervals. High-risk medications for cancer, anesthesia, and diabetes (insulin), among others can thus be safely delivered using infusion pumps. A variety of infusion pumps are available in the market including ambulatory pumps, volumetric pumps, syringe pumps, enteral pumps, insulin pumps, and implantable pumps.
Accurate engineering of infusion pumps is very essential to avoid over- or under-infusion of medications. To ensure safe usage of these devices, the U.S. FDA issued a three step program in 2010:
In January 2017, the regulatory body issued a statement addressing caution in MRI scan of patients with implantable infusion pumps. It stated that only infusion pumps labeled as MR-conditional should be scanned safely under specific conditions mentioned by the manufacturer of infusion pump. Ambulatory infusion pumps offer the user a convenience to administer medications while on the move. The infusion pump market is attracting investments by non-existing market players. ICU Medical, Inc. acquired Hospira’s infusion pumps business from Pfizer, Inc. in February 2017 for US$ 900 million.
This report segments the global infusion pumps market on the basis of product type, application, channel type, end user, and geography. On the basis of product type, the market is categorized into ambulatory pumps, volumetric pumps, syringe pumps, enteral, insulin, implantable, patient controlled analgesia pumps and pump accessories. On the basis of application, the market is segmented into chemotherapy/oncology, pediatrics/neonatology, analgesia, gastroenterology, hematology, diabetes. On the basis of channel type, the global infusion pumps market is segmented into single channel and multi-channel pumps. The end user segment is divided into hospitals, ambulatory clinics, home care, clinics and others. For comprehensive understanding of market dynamics, the global infusion pumps market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 100 market data tables and 30 figures on "Infusion Pumps Market - Global forecast to 2024”.
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.